ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.

Hans-Peter HartungThomas BergerRobert A BermelBruno BrochetWilliam M CarrollTrygve HolmøyRana KarabudakJoep KillesteinCarlos NosFrancesco PattiAmy Perrin RossLudo VanopdenboschTimothy VollmerRegine BuffelsMonika GarasKaren KadnerMarianna ManfriniQing WangMark S Freedman

Published in: Journal of neurology (2024)

March 21, 2017.

Keyphrases

low dose
convolutional neural network
neural network
deep learning